Price$651.24+178.59 (+37.78%)
2026-06-162026-09-18
News · 26 weeks71-9%
2026-03-292026-09-20
Mix3490d
- Insider23(68%)
- SEC Filings3(9%)
- Analyst3(9%)
- Earnings2(6%)
- Other2(6%)
- Dividends1(3%)
Latest news
25 items- ANALYSTThermo Fisher upgraded by UBS with a new price targetUBS upgraded Thermo Fisher from Neutral to Buy and set a new price target of $730.00
- ANALYSTCLSA initiated coverage on Thermo Fisher with a new price targetCLSA initiated coverage of Thermo Fisher with a rating of Outperform and set a new price target of $748.00
- INSIDERExecutive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERVP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERPresident & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- PRThermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET).You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com.About Thermo Fisher ScientificThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytic
- INSIDERChairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $172,439 worth of shares (275 units at $627.05) as part of a pre-agreed trading plan (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N exercised 20,000 shares at a strike of $309.63 and sold $12,561,823 worth of shares (20,000 units at $628.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSr. VP and Chief HR Officer Britt Lisa P. sold $7,014,093 worth of shares (11,440 units at $613.12) and exercised 11,440 shares at a strike of $418.32, decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERExecutive Vice President Shafer Michael D exercised 25,500 shares at a strike of $370.58 and sold $15,300,000 worth of shares (25,500 units at $600.00) as part of a pre-agreed trading plan (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- PRThermo Fisher Scientific Completes Sale of its Microbiology Business to AstorgThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. The business generated $645 million in revenue in 2025 and was part of Thermo Fisher's Specialty Diagnostics segment. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annu
- INSIDERVP & Chief Accounting Officer Holmes Joseph R. exercised 420 shares at a strike of $309.63 and sold $245,620 worth of shares (420 units at $584.81) (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $2,862,002 worth of shares (4,883 units at $586.12) as part of a pre-agreed trading plan (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSr. VP and Chief HR Officer Britt Lisa P. exercised 5,850 shares at a strike of $309.63 and sold $3,393,000 worth of shares (5,850 units at $580.00), decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,616,967 worth of shares (15,000 units at $574.46) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERChairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,628,434 worth of shares (15,000 units at $575.23) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- SECSEC Form 10-Q filed by Thermo Fisher Scientific Inc10-Q - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- INSIDERPresident & COO Pettiti Gianluca sold $226,000 worth of shares (400 units at $565.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 24,651 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Reports Second Quarter 2026 ResultsRevenue Grew 10% Including 5% Organic Revenue Growth Grew GAAP Diluted EPS 9% and Adjusted EPS 13% Customer Activity Across Our End Markets Continued to Strengthen Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2026. Second Quarter Highlights Second quarter revenue grew 10% to $11.99 billion Second quarter GAAP diluted earnings per share (EPS) grew 9% to $4.68 Second quarter adjusted EPS grew 13% to $6.03 "We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellent execution and the power of
TMO FAQ
7 questionsWhat does Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in...Where does TMO stock trade?
Thermo Fisher Scientific Inc (TMO) is listed on NYSE.What sector and industry is TMO in?
Thermo Fisher Scientific Inc operates in the Industrials sector, Industrial Machinery/Components industry.Does TMO pay a dividend?
TMO's most recent ex-dividend date was 2026-09-15 with a cash dividend of $0.47 per share. No future ex-date is on file yet.What are analysts saying about TMO?
Thermo Fisher Scientific Inc has had 8 recent analyst actions on file. The most recent action was from UBS: Buy on 2026-09-09.What companies are similar to TMO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), DE (Deere & Company), ETN (Eaton Corporation PLC), DHR (Danaher Corporation). Compare TMO side-by-side with any of them on Quantisnow.How can I track TMO on Quantisnow?
Quantisnow aggregates Thermo Fisher Scientific Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TMO to receive live email and push alerts on every new disclosure.